Educational article
Sulfonamides and trimethoprim
Sulfonamides and trimethoprim block different steps in bacterial folate metabolism. Co-trimoxazole combines sulfamethoxazole and trimethoprim. Sequential targeting explains the combination’s rationale, but activity…
Overview
Sulfonamides and trimethoprim block different steps in bacterial folate metabolism. Co-trimoxazole combines sulfamethoxazole and trimethoprim. Sequential targeting explains the combination’s rationale, but activity depends on the species and mechanisms of the particular isolate.
Biology and practical meaning
Altered target enzymes, including acquired sul and dfr determinants, can confer resistance. Medium composition can influence testing. The combination is tested and interpreted under an accepted standard rather than by independently adding two susceptibility categories.
Spectrum, exposure and AST
Spectrum describes the range of organisms an agent can act against; activity against a particular isolate is assessed separately. Access to the target, target changes, enzymes and efflux can alter activity. Agents in the same class are not completely interchangeable.
Pharmacokinetics describes distribution and elimination; pharmacodynamics links exposure to effect. Blood concentrations and exposure at the infection site can differ. A lower MIC number for a different antibiotic therefore does not establish superior clinical activity.
S, I and R are interpreted using a current standard for the organism–agent pair. Under EUCAST, I means susceptible with increased exposure. It does not mean resistant and does not independently specify a treatment regimen. Decisions also depend on the site, patient, contraindications, interactions and current guidance. This article explains mechanisms and terminology. The 2025 AWaRe classification concerns use policy, while the 2022 AWaRe book has subsequent updates; neither replaces an individual AST result.
Sources
Read next
Educational material from AMR Atlas. Does not replace clinical guidance or laboratory procedures.